Proem Advisors
HIMS icon

Proem Advisors’s Hims & Hers Health HIMS Stock Holding History

Proem Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500,000
Closed -$24.9M – 46
2025
Q2 		$24.9M Buy
500,000
+50,000
+11% +$2.26M 3.28% 9
2025
Q1 		$13.3M Hold
450,000
– – 3.99% 9
2024
Q4 		$10.9M Buy
+450,000
New +$11.1M 2.9% 17

Other funds holding HIMS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Proem Advisors's HIMS Position: Q3 2026 in Review

Proem Advisors reduced its Hims & Hers Health (HIMS) stake by 9.1% in Q3 2026, selling an estimated $307K and leaving 100,000 shares worth $2.98M. The position accounts for 0.21% of the portfolio, ranked #39.

Proem Advisors first reported a position in HIMS in Q4 2024 and has held it in 8 quarters since. The position peaked at $22.9M in Q2 2025. 270 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Proem Advisors held 100,000 shares of Hims & Hers Health worth $2.98M as of Q3 2026.
  • Proem Advisors sold 10,000 Hims & Hers Health shares in Q3 2026, an estimated $307K.
  • Hims & Hers Health made up 0.21% of Proem Advisors's portfolio in Q3 2026, its #39 holding.
  • Proem Advisors first reported a position in Hims & Hers Health in Q4 2024 and has held it in 8 quarters since.
  • Proem Advisors's Hims & Hers Health position peaked at $22.9M in Q2 2025.
  • 270 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Proem Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.